Sharemaestro Newsreel

Certara, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CERT) 2026-08-04

This article presents the slide deck published by Certara, Inc. in conjunction with their 2026 Q2 earnings call held on August 4, 2026. The company reported Q2 EPS of $0.08, missing by $0.01, and revenue of $93.27M, a 10.81% year-over-year decrease, missing by $4.81M. …

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

HealthEquity, Inc. (NASDAQ: HQY) has announced that it will release its financial results for the second quarter of fiscal year 2027 on Thursday, August 27, 2026, before market open. Management will host a conference call at 8:30 a.m. ET on the same day to …

Certara Falls Short on Q2 2026: $0.08 EPS vs $0.10 Expected

Certara, Inc. reported Q2 2026 adjusted diluted earnings per share of $0.08, missing the consensus estimate of $0.10 by 11.1%. Revenue increased modestly by 1.0% year-over-year to $93.3 million, with the Software segment showing stronger growth. The company's stock remained largely unchanged, reflecting mixed …

How Certara’s Widening Losses Amid Modest Sales Growth Will Impact Certara (CERT) Investors

Certara, Inc. (CERT) reported a significant widening of its net loss to US$55.27 million in Q2 2026, despite modest sales growth. This financial deterioration raises concerns about the company's cost discipline and the return on its R&D and AI investments, particularly given its recent …

Certara (NASDAQ:CERT) Shares Gap Down on Disappointing Earnings

Earnings call transcript: HealthStream tops Q2 2026 estimates, shares rise

Certara (NASDAQ:CERT) Posts Earnings Results, Misses Expectations By $0.01 EPS

Earnings call transcript: Certara Q2 2026 miss sends shares down 16%

Certara reported Q2 2026 adjusted earnings of $0.08 per share and revenue of $93.3 million, missing analyst expectations and causing its stock to drop 16.08%. The company noted solid software growth but weakness in services and higher costs, reaffirming its full-year guidance while emphasizing …

Teladoc Health (TDOC) On Weaker Earnings And Guidance The Fair Value Debate Returns

Teladoc Health (TDOC) is facing renewed scrutiny after reporting weaker Q2 revenue, a wider net loss, and reduced full-year guidance, leading to a significant stock pullback. Despite a narrative suggesting the stock is 55.5% undervalued with a fair value of $15.00 due to its …

SOPHiA GENETICS (NASDAQ:SOPH) Issues Quarterly Earnings Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand – Company Announcement - FT.com

DarioHealth Corp. has expanded its cardiometabolic platform by introducing Dario Women™ and Dario Sleep™ solutions to address client demand for multi-condition offerings. These new programs integrate AI-powered engagement, behavioral coaching, and access to licensed healthcare providers to improve outcomes for women's health concerns like …

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

DarioHealth Corp. (Nasdaq: DRIO) announced it will release its second-quarter 2026 financial results on Tuesday, August 11, 2026, before market open. The AI-powered healthcare technology company will host a conference call and webcast at 8:30 a.m. Eastern Time, featuring its CEO, COO, and CFO …

Tempus AI model trained on 2.3M slides predicts patient outcomes

Tempus AI announced that its multimodal slide-level pathology foundation model, PRISM2, has demonstrated best-in-class performance in diagnostic and prognostic applications for cancer. Published in Nature Medicine, the study highlights PRISM2's ability to predict biomarker status and patient outcomes, including colorectal cancer recurrence-free survival, leveraging …

HealthStream revenue up 12.5% to USD 83.7M in Q2 2026

HealthStream, Inc. reported a 12.5% increase in revenue to $83.7 million for Q2 2026, compared to $74.4 million in Q2 2025. This growth was driven by acquisitions and expansion of existing solutions. The company also saw significant increases in operating income, net income, and …

DarioHealth launches women’s health and sleep programs By Investing.com

DarioHealth Corp. (NASDAQ:DRIO) has announced the launch of two new programs, Dario Women and Dario Sleep, expanding its cardiometabolic healthcare platform. These programs integrate digital engagement, behavioral coaching, and clinical care, targeting women's health during perimenopause and menopause, and obstructive sleep apnea. Both are …

PHR Stockholders Have Rights – If You Lost Money Investing in Phreesia, Inc.

Robbins LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors about the sustainability of its Network Solutions business growth …

Earnings To Watch: American Well Corp (AMWL) Q2 2026 -- GF Value Sees 43% Downside

Certara, Inc. 2026: Revenue $93.27M, EPS ($0.36) — 10-Q Summary

Certara, Inc. reported its first-quarter 2026 results, showing a 1% revenue increase to $93.27M. Despite this growth, the company experienced a significant net loss of $55.27M, or ($0.36) diluted EPS, compared to a smaller loss in the prior year. Revenue growth was primarily driven …

[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer)

SOPHiA GENETICS SA filed a Form 6-K Current Report (Foreign Issuer) with the SEC on August 4, 2026, which includes unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2026, and management's discussion and analysis of financial condition …

nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks Shares Are Soaring, What You Need To Know

Shares of nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks surged following easing geopolitical tensions and a new wave of AI-driven M&A activity. A diplomatic resolution regarding the Strait of Hormuz led to a drop in Treasury yields, benefiting growth-oriented tech equities. The …

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 34.63% Potential Upside in the Healthcare Sector

Schrodinger, Inc. (SDGR) is a healthcare sector player focused on drug and material discovery through its computational platform, offering a potential upside of 34.63% to its average analyst target price of $20.57. Despite current financial challenges like negative P/E and revenue growth, reflecting significant …

Precision Trading with Certara Inc. (CERT) Risk Zones

The article provides a detailed analysis of Certara Inc. (CERT) using AI models to suggest trading strategies across different risk profiles and holding periods. It highlights a strong near-to-mid-term sentiment but a weak long-term outlook, identifying specific entry, target, and stop-loss zones for position, …

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth

MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Analysts have given MiniMed Group Inc (NASDAQ:MMED) a "Moderate Buy" consensus recommendation, with 13 buy ratings, two holds, and one sell from 16 firms. The average 12-month price target is $21.62, higher than the stock's opening price of $18.05. Despite mixed recent analyst actions …

Digital Health Firm Launches Integrated GLP-1 Program

DarioHealth Corp. (DRIO:NASDAQ) has launched an Integrated GLP-1 Program, combining its digital platform with Beluga Health's clinical oversight to offer end-to-end support for GLP-1 therapies, including evaluation, prescribing, and chronic care management. This program aims to address the rapidly growing GLP-1 market, targeting employers …

Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026

Teladoc Health, Inc. has announced the appointment of Mark V. Anquillare to its board of directors, effective August 3, 2026. Mr. Anquillare, former president and COO of Verisk Analytics, brings over 30 years of financial and executive leadership experience. He will serve on the …

Form 4 Waystar Holding Corp For: 3 August By Investing.com

This article announces the filing of a Form 4 for Waystar Holding Corp. on August 3rd. It is a brief, news-style piece published by Investing.com. The content mainly serves as a placeholder for a financial filing announcement, typical for financial news feeds.

OMCL|Omnicell Inc|Price:37.525|Chg%:+2.155

This article provides a comprehensive stock analysis of Omnicell Inc (OMCL), highlighting its relatively healthy fundamentals, significant growth potential, and fair valuation. Despite recent weak stock market performance, the company maintains strong fundamentals, and analysts have issued "Buy" ratings with a high price target. …

Earnings To Watch: LifeMD Inc (LFMD) Q2 2026 -- GF Value Sees 92% Upside

Simulations Plus (NASDAQ:SLP) Stock Price Passes Above 200-Day Moving Average - Here's Why

Certara Q2 Earnings Call Highlights

HealthStream (NASDAQ:HSTM) Hits New 1-Year High After Earnings Beat

American Well (AMWL) Earnings Date and Reports 2026

American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates

SOPHiA GENETICS Reports Second Quarter 2026 Results